443 related articles for article (PubMed ID: 28972541)
1. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
Doran AC; Ozcan L; Cai B; Zheng Z; Fredman G; Rymond CC; Dorweiler B; Sluimer JC; Hsieh J; Kuriakose G; Tall AR; Tabas I
J Clin Invest; 2017 Nov; 127(11):4075-4089. PubMed ID: 28972541
[TBL] [Abstract][Full Text] [Related]
2. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.
Cai B; Thorp EB; Doran AC; Sansbury BE; Daemen MJ; Dorweiler B; Spite M; Fredman G; Tabas I
J Clin Invest; 2017 Feb; 127(2):564-568. PubMed ID: 28067670
[TBL] [Abstract][Full Text] [Related]
3. siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice.
Tao W; Yurdagul A; Kong N; Li W; Wang X; Doran AC; Feng C; Wang J; Islam MA; Farokhzad OC; Tabas I; Shi J
Sci Transl Med; 2020 Jul; 12(553):. PubMed ID: 32718990
[TBL] [Abstract][Full Text] [Related]
4. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
[TBL] [Abstract][Full Text] [Related]
5. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
[TBL] [Abstract][Full Text] [Related]
6. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
Yu P; Qian AS; Chathely KM; Trigatti BL
Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
[TBL] [Abstract][Full Text] [Related]
7. Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2
Wang W; Liu W; Fidler T; Wang Y; Tang Y; Woods B; Welch C; Cai B; Silvestre-Roig C; Ai D; Yang YG; Hidalgo A; Soehnlein O; Tabas I; Levine RL; Tall AR; Wang N
Circ Res; 2018 Nov; 123(11):e35-e47. PubMed ID: 30571460
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
Kojima Y; Downing K; Kundu R; Miller C; Dewey F; Lancero H; Raaz U; Perisic L; Hedin U; Schadt E; Maegdefessel L; Quertermous T; Leeper NJ
J Clin Invest; 2014 Mar; 124(3):1083-97. PubMed ID: 24531546
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228
[TBL] [Abstract][Full Text] [Related]
10. Disrupting LXRα phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation.
Gage MC; Bécares N; Louie R; Waddington KE; Zhang Y; Tittanegro TH; Rodríguez-Lorenzo S; Jathanna A; Pourcet B; Pello OM; De la Rosa JV; Castrillo A; Pineda-Torra I
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6556-E6565. PubMed ID: 29950315
[TBL] [Abstract][Full Text] [Related]
11. Assessing Efferocytosis in Atherosclerotic Lesions In Situ.
Yurdagul A
Methods Mol Biol; 2022; 2419():561-567. PubMed ID: 35237988
[TBL] [Abstract][Full Text] [Related]
12. DBA/2J Haplotype on Distal Chromosome 2 Reduces Mertk Expression, Restricts Efferocytosis, and Increases Susceptibility to Atherosclerosis.
Kayashima Y; Makhanova N; Maeda N
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):e82-e91. PubMed ID: 28473436
[TBL] [Abstract][Full Text] [Related]
13. Immunoproteasome subunit β5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice.
Liao J; Xie Y; Lin Q; Yang X; An X; Xia Y; Du J; Wang F; Li HH
J Pathol; 2020 Mar; 250(3):275-287. PubMed ID: 31758542
[TBL] [Abstract][Full Text] [Related]
14. ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis.
Heo KS; Cushman HJ; Akaike M; Woo CH; Wang X; Qiu X; Fujiwara K; Abe J
Circulation; 2014 Jul; 130(2):180-91. PubMed ID: 25001623
[TBL] [Abstract][Full Text] [Related]
15. Allograft inflammatory factor-1 supports macrophage survival and efferocytosis and limits necrosis in atherosclerotic plaques.
Egaña-Gorroño L; Chinnasamy P; Casimiro I; Almonte VM; Parikh D; Oliveira-Paula GH; Jayakumar S; Law C; Riascos-Bernal DF; Sibinga NES
Atherosclerosis; 2019 Oct; 289():184-194. PubMed ID: 31439353
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice.
Kyaw T; Winship A; Tay C; Kanellakis P; Hosseini H; Cao A; Li P; Tipping P; Bobik A; Toh BH
Circulation; 2013 Mar; 127(9):1028-39. PubMed ID: 23395974
[TBL] [Abstract][Full Text] [Related]
17. Protective Functions of Liver X Receptor α in Established Vulnerable Plaques: Involvement of Regulating Endoplasmic Reticulum-Mediated Macrophage Apoptosis and Efferocytosis.
Che X; Xiao Q; Song W; Zhang H; Sun B; Geng N; Tao Z; Shao Q; Pu J
J Am Heart Assoc; 2021 May; 10(10):e018455. PubMed ID: 33969692
[TBL] [Abstract][Full Text] [Related]
18. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.
Tao H; Yancey PG; Babaev VR; Blakemore JL; Zhang Y; Ding L; Fazio S; Linton MF
J Lipid Res; 2015 Aug; 56(8):1449-60. PubMed ID: 26059978
[TBL] [Abstract][Full Text] [Related]
19. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
Nishi C; Yanagihashi Y; Segawa K; Nagata S
J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
[TBL] [Abstract][Full Text] [Related]
20. Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.
Tajbakhsh A; Rezaee M; Kovanen PT; Sahebkar A
Pharmacol Ther; 2018 Aug; 188():12-25. PubMed ID: 29444453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]